AlloVir Earning Date (ALVR)

USA |NASDAQ |USD

ALVR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 4, 2022 Jun 2022 - - $-0.60
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 4, 2022 Jun 2022 - - $0.00

Allovir's next earnings date is Thursday, Aug 4, 2022 for the fiscal quarter ending Jun 2022.

ALVR Earnings Date & History Chart

ALVR Earnings & Revenue Forecast

ALVR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $-2.28 $-2.96 $-1.83

ALVR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-2.28 $-2.28 $-2.08

ALVR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $3.17M $0.00 $12.68M

ALVR Earnings Date & Revenue History

ALVR Earnings History

|
Show More
Show More

ALVR Revenue History

|
Show More
Show More

Allovir Next Earnings Date & Report

ALVR Next Earnings Date & Report Preview: Jun 2022 (FQ)

ALVR's next earnings date is Thursday, Aug 4, 2022 for the fiscal quarter ending Jun 30, 2022.

Allovir Previous Earnings Dates & Reports

ALVR Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Allovir's previous earnings date was May 5, 2022 for its fiscal quarter ended Mar 31, 2022.

The company reported a net income of $-43.86M.

Free cash flow for the quarter was $-46.48M , compared to $-27.70M last quarter and $-19.00M a year before.

ALVR ended the quarter with $23.13M in total debt, a decrease of -36.90% compared to the previous quarter, and an increase of 126.85% compared to the same quarter a year before.

ALVR Previous Earnings Date & Report Recap: Dec 2021 (FY)

Allovir's previous annual earnings date was Feb 10, 2022 for its fiscal year ended Dec 31, 2021.

ALVR's earnings per share (EPS) was $-2.74, missing the consensus analysts forecast of $-2.25 by 21.78% , and higher than the previous year's EPS (Dec 2020) by -41.33%.

Revenues were $0.00.

The company reported a net income of $-171.96M.

Allovir reported a free cash flow of $-106.34M for its fiscal year, compared to $-61.05M a year ago.

The company ended the fiscal year with $36.66M in total debt, an increase of 321.73% compared to the previous year.